148 related articles for article (PubMed ID: 37062475)
1. The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma.
Ebrahimi N; Far NP; Fakhr SS; Faghihkhorasani F; Miraghel SA; Chaleshtori SR; Rezaei-Tazangi F; Beiranvand S; Baziyar P; Manavi MS; Zarrabi A; Nabavi N; Ren J; Aref AR
Environ Res; 2023 Jul; 228():115914. PubMed ID: 37062475
[TBL] [Abstract][Full Text] [Related]
2. Lipid desaturation-associated endoplasmic reticulum stress regulates MYCN gene expression in hepatocellular carcinoma cells.
Qin XY; Su T; Yu W; Kojima S
Cell Death Dis; 2020 Jan; 11(1):66. PubMed ID: 31988297
[TBL] [Abstract][Full Text] [Related]
3. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
[TBL] [Abstract][Full Text] [Related]
4. Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance.
Hashemi M; Sabouni E; Rahmanian P; Entezari M; Mojtabavi M; Raei B; Zandieh MA; Behroozaghdam M; Mirzaei S; Hushmandi K; Nabavi N; Salimimoghadam S; Ren J; Rashidi M; Raesi R; Taheriazam A; Alexiou A; Papadakis M; Tan SC
Cell Mol Biol Lett; 2023 Apr; 28(1):33. PubMed ID: 37085753
[TBL] [Abstract][Full Text] [Related]
5. Human hepatocellular carcinoma: Protection by melatonin.
Mortezaee K
J Cell Physiol; 2018 Oct; 233(10):6486-6508. PubMed ID: 29672851
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
8. Dual effects of gossypol on human hepatocellular carcinoma via endoplasmic reticulum stress and autophagy.
Zhang G; Wang Z; Chen W; Cao Y; Wu J; Qiang G; Ji A; Wu J; Jiang C
Int J Biochem Cell Biol; 2019 Aug; 113():48-57. PubMed ID: 31128260
[TBL] [Abstract][Full Text] [Related]
9. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
[TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y
RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588
[TBL] [Abstract][Full Text] [Related]
11. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
Jin B; Wang W; Meng XX; Du G; Li J; Zhang SZ; Zhou BH; Fu ZH
BMC Cancer; 2016 Nov; 16(1):863. PubMed ID: 27821157
[TBL] [Abstract][Full Text] [Related]
12. BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.
Ma J; Zeng S; Zhang Y; Deng G; Qu Y; Guo C; Yin L; Han Y; Cai C; Li Y; Wang G; Bonkovsky HL; Shen H
Cancer Lett; 2017 Dec; 411():117-129. PubMed ID: 28987388
[TBL] [Abstract][Full Text] [Related]
13. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.
Li X; Zeng X
Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643
[TBL] [Abstract][Full Text] [Related]
14. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
[TBL] [Abstract][Full Text] [Related]
15. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
17. MiR-4319 induced an inhibition of epithelial-mesenchymal transition and prevented cancer stemness of HCC through targeting FOXQ1.
Han S; Shi Y; Sun L; Liu Z; Song T; Liu Q
Int J Biol Sci; 2019; 15(13):2936-2947. PubMed ID: 31853229
[TBL] [Abstract][Full Text] [Related]
18. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
Ding H; Liu J; Zou R; Cheng P; Su Y
J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
[TBL] [Abstract][Full Text] [Related]
20. Autophagy orchestrates resistance in hepatocellular carcinoma cells.
Seydi H; Nouri K; Rezaei N; Tamimi A; Hassan M; Mirzaei H; Vosough M
Biomed Pharmacother; 2023 May; 161():114487. PubMed ID: 36963361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
